Literature DB >> 20146695

Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.

Andrew L Mammen1.   

Abstract

Dermatomyositis (DM) and polymyositis (PM) are autoimmune myopathies characterized clinically by proximal muscle weakness, muscle inflammation, extramuscular manifestations, and frequently, the presence of autoantibodies. Although there is some overlap, DM and PM are separate diseases with different pathophysiological mechanisms. Furthermore, unique clinical phenotypes are associated with each of the myositis-specific autoantibodies (MSAs) associated with these disorders. This review will focus on the clinical features, pathology, and immunogenetics of PM and DM with an emphasis on the importance of autoantibodies in defining unique phenotypes and, perhaps, as clues to help elucidate the mechanisms of disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146695     DOI: 10.1111/j.1749-6632.2009.05119.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  51 in total

1.  Subacute progressive ophthalmoplegia associated with dermatomyositis.

Authors:  Satoshi Kono; Tomoyasu Bunai; Tatsuhiro Terada; Kumiko Shimoyama; Takashi Konishi; Kentaro Shirakawa; Hiroaki Miyajima
Journal:  J Neurol       Date:  2012-04-20       Impact factor: 4.849

2.  A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy.

Authors:  Lisa Christopher-Stine; Livia A Casciola-Rosen; Grace Hong; Tae Chung; Andrea M Corse; Andrew L Mammen
Journal:  Arthritis Rheum       Date:  2010-09

3.  Distinct profiles of myositis-specific autoantibodies in Chinese and Japanese patients with polymyositis/dermatomyositis.

Authors:  Zhiyong Chen; Wei Hu; Yan Wang; Ziwei Guo; Lingyun Sun; Masataka Kuwana
Journal:  Clin Rheumatol       Date:  2015-04-24       Impact factor: 2.980

Review 4.  Myositis-specific autoantibodies: detection and clinical associations.

Authors:  Sander H J van Dooren; Walther J van Venrooij; Ger J M Pruijn
Journal:  Auto Immun Highlights       Date:  2011-03-23

Review 5.  Clinical features, pathogenesis and treatment of juvenile and adult dermatomyositis.

Authors:  Angela B Robinson; Ann M Reed
Journal:  Nat Rev Rheumatol       Date:  2011-09-27       Impact factor: 20.543

6.  Expression of the dermatomyositis autoantigen transcription intermediary factor 1γ in regenerating muscle.

Authors:  Payam Mohassel; Paul Rosen; Livia Casciola-Rosen; Katherine Pak; Andrew L Mammen
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

Review 7.  The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.

Authors:  Yang Mao-Draayer; Jeffrey Sarazin; David Fox; Elena Schiopu
Journal:  Clin Immunol       Date:  2016-11-23       Impact factor: 3.969

8.  Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Authors:  Rossella Neri; Simone Barsotti; Barsotti Simone; Valentina Iacopetti; Giacomo Iacopetti; Pasquale Pepe; Anna d'Ascanio; Antonio Gaetano Tavoni; Marta Mosca; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

9.  Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.

Authors:  Rohit Aggarwal; Elaine Cassidy; Noreen Fertig; Diane Carol Koontz; Mary Lucas; Dana P Ascherman; Chester V Oddis
Journal:  Ann Rheum Dis       Date:  2013-02-19       Impact factor: 19.103

10.  Brief report: antisynthetase syndrome-associated myocarditis.

Authors:  Kavita Sharma; Ana-Maria Orbai; Dipan Desai; Oscar H Cingolani; Marc K Halushka; Lisa Christopher-Stine; Andrew L Mammen; Katherine C Wu; Sammy Zakaria
Journal:  J Card Fail       Date:  2014-07-29       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.